MATCHPOINT THERAPEUTICS INC.

Profile

Company Names

MATCHPOINT THERAPEUTICS INC.

Addresses

ONE KENDALL SQUARE, BUILDING 400 SUITE 201, CAMBRIDGE, MA 02139

Phone Numbers

617-620-6280

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2021

State Incorporated:

DELAWARE

Total Amount Raised:

$41,999,994.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2022-10-05 
$41,999,994.00 
$69,999,990.00 
$27,999,996.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DANIEL 
 
BECKER 
DIRECTOR
WATCHWITH, INC.   |  NEURANA PHARMACEUTICALS, INC.   |  PRINCIPIA BIOPHARMA INC.   |  PANDION THERAPEUTICS HOLDCO LLC   |  DTX PHARMA, INC.   |  DAY ONE BIOPHARMACEUTICALS HOLDING CO LLC   |  MATCHPOINT THERAPEUTICS INC.   |  ARETEIA THERAPEUTICS, INC.
BRUCE 
 
BOOTH 
DIRECTOR
MIRAGEN THERAPEUTICS INC   |  AVILA THERAPEUTICS INC   |  ZAFGEN, INC.   |  NIMBUS DISCOVERY, LLC   |  ON-Q-ITY, INC.   |  NUMERATE INC   |  UNUM THERAPEUTICS, INC.   |  LYSOSOMAL THERAPEUTICS, INC.   |  AVROBIO, INC.   |  MAGENTA THERAPEUTICS, INC.   |  ATLAS VENTURE FUND XI, L.P.   |  RODIN THERAPEUTICS, INC.   |  ATLAS VENTURE OPPORTUNITY FUND I, L.P.   |  ATLAS VENTURE FUND XII, L.P.   |  VIGIL NEUROSCIENCE, INC.   |  ATLAS VENTURE OPPORTUNITY FUND II, L.P.   |  ATLAS VENTURE FUND XIII, L.P.   |  MATCHPOINT THERAPEUTICS INC.   |  ATLAS VENTURE FUND XIV, L.P.   |  ATLAS VENTURE OPPORTUNITY FUND ILL, L.P.
JASON 
 
HAFLER 
DIRECTOR
NEUROVIA, INC.   |  EXPANSION THERAPEUTICS, INC.   |  ICOSAVAX, INC.   |  ESCIENT PHARMACEUTICALS INC   |  ABCURO, INC.   |  MATCHPOINT THERAPEUTICS INC.   |  CHARACTER BIOSCIENCES, INC.   |  STAR THERAPEUTICS LLC
ANDRE 
 
TURENNE 
EXECUTIVE OFFICER, DIRECTOR
MERU NETWORKS INC   |  PGP CORP   |  ALTIERRE CORP   |  USER TESTING, INC.   |  PANTERRA NETWORKS INC   |  AIDASH INC   |  COGNIAC CORP   |  MATCHPOINT THERAPEUTICS INC.   |  APERIO SYSTEMS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-10-17
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-10-05 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#